Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UroQuest Medical was a medical technology company that developed and marketed proprietary products for the urology market, with a specific focus on the treatment of urinary incontinence and the management of catheterization. The company's primary product line included the Uro-Prep system, a pre-packaged, sterile catheterization kit designed to reduce the risk of urinary tract infections. Headquartered in Huntsville, Alabama, the company became a leader in specialized urological devices during the 1990s. In 1998, UroQuest Medical was acquired by C. R. Bard, a major global medical technology firm, for approximately $45 million. This acquisition integrated UroQuest's innovative catheter technologies into Bard's extensive urological portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UroQuest Medical.